Adverse Events Module
For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
Adverse Events Module
Event Groups
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Zanubrutinib on Day 1 | Single oral dose zanubrutinib 320 mg on Day 1 | 0 | None | 0 | 13 | 1 | 13 | View |
| Rifabutin on Days 3 to 10 | Once daily oral rifabutin 300 mg on Days 3 to 10 | 0 | None | 0 | 13 | 6 | 13 | View |
| Zanubrutinib + Rifabutin on Day 11 | Single oral dose zanubrutinib 320 mg and once daily oral rifabutin 300 mg on Day 11 | 0 | None | 0 | 13 | 0 | 13 | View |